NIH-funded research R01 grant

Vaccine responses in older people living with HIV

Official title: Vaccine immunity and inflammation in the aging person living with HIV

Funded at Hennepin Healthcare Research Institute · NIH-11390461 · Data updated 2026-11-12

This project looks at how age and HIV infection affect how well a pneumococcal vaccine works, especially in older adults.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHennepin Healthcare Research Institute
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$667,915
NIH project number5R01AG084437-03
Project IDNIH-11390461 on NIH RePORTER

Who could benefit from this research

Could help

Adults with HIV aged 50 and older, and age-matched HIV-uninfected controls, including both younger and older cohorts.

Less likely to help

Healthy adults without HIV or those not receiving the pneumococcal vaccine may not directly benefit.

What this research studies

Older adults living with HIV often have ongoing inflammation that could weaken vaccine responses. The study will follow a diverse group of participants to compare immune responses to the PCV20 vaccine across age groups and HIV status, tracking antibodies, B cells, and CD4 T cells over two years. By analyzing how age and chronic inflammation interact with HIV, researchers aim to understand why vaccines may be less effective in this population and what could improve protection.

Why it matters

Potential benefit: If successful, findings could guide better vaccination strategies and timing for older people with HIV to improve protection against pneumococcal disease.

How similar studies have gone: Previous work shows age and immune status affect vaccine responses, but this study directly compares age and HIV status with long-term follow-up.

Where this research is happening

  • Hennepin Healthcare Research Institute
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Frosch, Anne Elizabeth Parker — Hennepin Healthcare Research Institute
  • Study coordinator: Frosch, Anne Elizabeth Parker

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.